Process View
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to steroid hormone stimulus"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
ESR1 | estrogen receptor 1 | 0.899 | ||
EGFR | epidermal growth factor receptor | 0.839 | ||
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.701 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.672 | Human | |
CREBBP | CREB binding protein | 0.583 | ||
SMN1 | survival of motor neuron 1, telomeric | 0.494 | ||
SMAD4 | SMAD family member 4 | 0.312 | ||
FSTL1 | follistatin-like 1 | 0.296 | ||
PPARA | peroxisome proliferator-activated receptor alpha | 0.296 | ||
WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.285 | ||
AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.223 | Human | |
NRP1 | neuropilin 1 | 0.192 | ||
BMPR1A | bone morphogenetic protein receptor, type IA | 0.182 | ||
ARIH2 | ariadne homolog 2 (Drosophila) | 0.181 | ||
CDK11B | cyclin-dependent kinase 11B | 0.177 | ||
AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.176 | Human | |
SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.176 | ||
BMPR1B | bone morphogenetic protein receptor, type IB | 0.173 | ||
S100A10 | S100 calcium binding protein A10 | 0.171 | ||
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.140 | ||
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.140 | ||
AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.137 | ||
RNF144B | ring finger protein 144B | 0.136 | ||
APAF1 | apoptotic peptidase activating factor 1 | 0.128 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.120 | ||
NCOA1 | nuclear receptor coactivator 1 | 0.118 | ||
CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.116 | ||
BRCA1 | breast cancer 1, early onset | 0.115 | ||
PDCD6 | programmed cell death 6 | 0.105 | ||
HDAC1 | histone deacetylase 1 | 0.104 | ||
AR | androgen receptor | 0.102 | ||
PLAU | plasminogen activator, urokinase | 0.098 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.096 | ||
EIF3F | eukaryotic translation initiation factor 3, subunit F | 0.091 | ||
CUEDC2 | CUE domain containing 2 | 0.087 | ||
KLHL24 | kelch-like 24 (Drosophila) | 0.086 | ||
PLAT | plasminogen activator, tissue | 0.081 | Rat | |
RUVBL1 | RuvB-like 1 (E. coli) | 0.078 | ||
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.078 | ||
NCOR2 | nuclear receptor corepressor 2 | 0.077 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.077 | Human | |
CBX1 | chromobox homolog 1 | 0.072 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.067 | Rat | |
RXRA | retinoid X receptor, alpha | 0.065 | ||
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.064 | ||
PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 0.058 | ||
ANXA1 | annexin A1 | 0.057 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.056 | ||
TP53 | tumor protein p53 | 0.053 | ||
ANXA2 | annexin A2 | 0.053 | Human | |
DUSP6 | dual specificity phosphatase 6 | 0.052 | ||
JDP2 | Jun dimerization protein 2 | 0.051 | ||
NMI | N-myc (and STAT) interactor | 0.050 | ||
MED1 | mediator complex subunit 1 | 0.048 | ||
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.047 | ||
TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.046 | ||
STAT5A | signal transducer and activator of transcription 5A | 0.046 | ||
INSR | insulin receptor | 0.042 | ||
NCOA2 | nuclear receptor coactivator 2 | 0.042 | ||
IFNGR1 | interferon gamma receptor 1 | 0.042 | ||
NCOA3 | nuclear receptor coactivator 3 | 0.041 | ||
IL10RA | interleukin 10 receptor, alpha | 0.041 | ||
IGF1R | insulin-like growth factor 1 receptor | 0.039 | ||
ARNT | aryl hydrocarbon receptor nuclear translocator | 0.038 | ||
EMP1 | epithelial membrane protein 1 | 0.037 | ||
S100A11 | S100 calcium binding protein A11 | 0.037 | ||
THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.037 | Human | |
CRHR1 | corticotropin releasing hormone receptor 1 | 0.036 | ||
S100A6 | S100 calcium binding protein A6 | 0.036 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.034 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.033 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.033 | ||
THBS1 | thrombospondin 1 | 0.033 | ||
SMAD9 | SMAD family member 9 | 0.032 | ||
IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.032 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.032 | ||
CCT5 | chaperonin containing TCP1, subunit 5 (epsilon) | 0.032 | ||
FN1 | fibronectin 1 | 0.031 | ||
GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.031 | ||
FADD | Fas (TNFRSF6)-associated via death domain | 0.030 | ||
FAM46A | family with sequence similarity 46, member A | 0.030 | ||
RARA | retinoic acid receptor, alpha | 0.029 | ||
ESR2 | estrogen receptor 2 (ER beta) | 0.029 | Human Zebrafish Rat | |
EGR3 | early growth response 3 | 0.029 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.029 | ||
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.028 | ||
SUZ12 | suppressor of zeste 12 homolog (Drosophila) | 0.028 | ||
PPP5C | protein phosphatase 5, catalytic subunit | 0.028 | ||
NOG | noggin | 0.028 | ||
TRADD | TNFRSF1A-associated via death domain | 0.027 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.027 | ||
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | 0.027 | ||
ENG | endoglin | 0.027 | ||
ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.027 | ||
CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) | 0.027 | ||
HNF4A | hepatocyte nuclear factor 4, alpha | 0.026 | ||
WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.025 | ||
SENP3 | SUMO1/sentrin/SMT3 specific peptidase 3 | 0.025 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.025 | ||
PGF | placental growth factor | 0.025 | ||
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.025 | ||
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.024 | ||
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.024 | ||
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.024 | ||
EZH2 | enhancer of zeste homolog 2 (Drosophila) | 0.024 | ||
TGFB3 | transforming growth factor, beta 3 | 0.024 | ||
XIAP | X-linked inhibitor of apoptosis | 0.024 | ||
LAT | linker for activation of T cells | 0.023 | ||
FOXO1 | forkhead box O1 | 0.023 | ||
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.023 | ||
PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.023 | ||
NRIP1 | nuclear receptor interacting protein 1 | 0.023 | ||
SPDEF | SAM pointed domain containing ets transcription factor | 0.022 | ||
SKIL | SKI-like oncogene | 0.022 | ||
TCF4 | transcription factor 4 | 0.022 | ||
KDELR2 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 | 0.022 | ||
SNAI1 | snail homolog 1 (Drosophila) | 0.022 | ||
PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.022 | ||
C16orf53 | chromosome 16 open reading frame 53 | 0.021 | ||
PRMT2 | protein arginine methyltransferase 2 | 0.021 | ||
MPDZ | multiple PDZ domain protein | 0.021 | ||
PML | promyelocytic leukemia | 0.021 | ||
ACACA | acetyl-CoA carboxylase alpha | 0.021 | ||
BAX | BCL2-associated X protein | 0.021 | ||
TSC22D1 | TSC22 domain family, member 1 | 0.021 | ||
EGR2 | early growth response 2 | 0.020 | ||
SSR2 | signal sequence receptor, beta (translocon-associated protein beta) | 0.020 | ||
FKBP2 | FK506 binding protein 2, 13kDa | 0.020 | ||
EMP3 | epithelial membrane protein 3 | 0.019 | ||
HIPK2 | homeodomain interacting protein kinase 2 | 0.019 | ||
MYOD1 | myogenic differentiation 1 | 0.019 | Mouse | |
TK1 | thymidine kinase 1, soluble | 0.019 | ||
H3F3C | H3 histone, family 3C | 0.019 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.019 | ||
NPC2 | Niemann-Pick disease, type C2 | 0.019 | ||
IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.019 | ||
PAX7 | paired box 7 | 0.019 | ||
ARRDC3 | arrestin domain containing 3 | 0.019 | ||
RPN2 | ribophorin II | 0.018 | ||
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.018 | ||
GSN | gelsolin | 0.018 | ||
MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.018 | ||
GABARAP | GABA(A) receptor-associated protein | 0.018 | ||
NCOA7 | nuclear receptor coactivator 7 | 0.018 | ||
ANXA4 | annexin A4 | 0.018 | Human | |
ACTR6 | ARP6 actin-related protein 6 homolog (yeast) | 0.018 | ||
DMAP1 | DNA methyltransferase 1 associated protein 1 | 0.018 | ||
CBX5 | chromobox homolog 5 | 0.018 | ||
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.018 | Human | |
LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.017 | ||
TTN | titin | 0.017 | ||
SYK | spleen tyrosine kinase | 0.017 | ||
SSTR2 | somatostatin receptor 2 | 0.016 | Rat | |
HDAC3 | histone deacetylase 3 | 0.016 | ||
HIC1 | hypermethylated in cancer 1 | 0.016 | ||
APP | amyloid beta (A4) precursor protein | 0.016 | ||
MED25 | mediator complex subunit 25 | 0.016 | ||
HRG | histidine-rich glycoprotein | 0.016 | ||
LAS1L | LAS1-like (S. cerevisiae) | 0.016 | ||
PRKRIR | protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) | 0.016 | ||
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.016 | ||
KLF9 | Kruppel-like factor 9 | 0.016 | ||
WWOX | WW domain containing oxidoreductase | 0.016 | ||
GABRA3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 | 0.015 | ||
TMSB10 | thymosin beta 10 | 0.015 | ||
NOMO1 | NODAL modulator 1 | 0.015 | ||
HMGN2 | high mobility group nucleosomal binding domain 2 | 0.015 | ||
UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | 0.015 | Human | |
MYOZ1 | myozenin 1 | 0.015 | ||
VEZF1 | vascular endothelial zinc finger 1 | 0.015 | ||
FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.015 | ||
RET | ret proto-oncogene | 0.015 | ||
TM4SF1 | transmembrane 4 L six family member 1 | 0.015 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.015 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.014 | ||
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.014 | ||
LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.014 | ||
GRINA | glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) | 0.014 | ||
MYLK2 | myosin light chain kinase 2 | 0.014 | ||
ARL6IP1 | ADP-ribosylation factor-like 6 interacting protein 1 | 0.014 | ||
HNRNPD | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) | 0.014 | ||
EP300 | E1A binding protein p300 | 0.014 | ||
MAPK1 | mitogen-activated protein kinase 1 | 0.014 | ||
CDK19 | cyclin-dependent kinase 19 | 0.014 | ||
SEC61B | Sec61 beta subunit | 0.014 | ||
ANXA5 | annexin A5 | 0.014 | Human | |
THBS2 | thrombospondin 2 | 0.014 | ||
SP1 | Sp1 transcription factor | 0.014 | ||
EPOR | erythropoietin receptor | 0.013 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.013 | ||
CD34 | CD34 molecule | 0.013 | ||
GBP2 | guanylate binding protein 2, interferon-inducible | 0.013 | ||
AHR | aryl hydrocarbon receptor | 0.013 | Rat | |
APOD | apolipoprotein D | 0.013 | ||
TRIM43 | tripartite motif containing 43 | 0.013 | ||
ITGB5 | integrin, beta 5 | 0.013 | ||
GRIP1 | glutamate receptor interacting protein 1 | 0.013 | ||
UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | 0.013 | Human | |
ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.013 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.013 | ||
NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.013 | Zebrafish Mouse Rat | |
ADAMTSL4 | ADAMTS-like 4 | 0.013 | ||
SMAD2 | SMAD family member 2 | 0.013 | ||
DDOST | dolichyl-diphosphooligosaccharide--protein glycosyltransferase | 0.013 | ||
DES | desmin | 0.013 | ||
CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.013 | ||
TRIM24 | tripartite motif containing 24 | 0.013 | ||
FHL2 | four and a half LIM domains 2 | 0.013 | ||
RNF31 | ring finger protein 31 | 0.013 | ||
TRO | trophinin | 0.012 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.012 | ||
NEB | nebulin | 0.012 | ||
MED13L | mediator complex subunit 13-like | 0.012 | ||
SFRP1 | secreted frizzled-related protein 1 | 0.012 | ||
SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.012 | ||
GHR | growth hormone receptor | 0.012 | ||
BCL2 | B-cell CLL/lymphoma 2 | 0.012 | ||
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.012 | ||
ACTA1 | actin, alpha 1, skeletal muscle | 0.012 | ||
DLG2 | discs, large homolog 2 (Drosophila) | 0.012 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.012 | ||
ITGB1BP2 | integrin beta 1 binding protein (melusin) 2 | 0.012 | ||
ADAM9 | ADAM metallopeptidase domain 9 | 0.012 | ||
JAK2 | Janus kinase 2 | 0.012 | Mouse | |
POLR2E | polymerase (RNA) II (DNA directed) polypeptide E, 25kDa | 0.012 | ||
CD63 | CD63 molecule | 0.012 | ||
FDFT1 | farnesyl-diphosphate farnesyltransferase 1 | 0.012 | ||
ORM1 | orosomucoid 1 | 0.012 | ||
ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.012 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.012 | ||
C20orf20 | chromosome 20 open reading frame 20 | 0.012 | ||
PTGES3 | prostaglandin E synthase 3 (cytosolic) | 0.012 | ||
MAGEA2 | melanoma antigen family A, 2 | 0.012 | ||
TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.012 | ||
TP73 | tumor protein p73 | 0.012 | ||
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.012 | ||
BID | BH3 interacting domain death agonist | 0.012 | ||
RARB | retinoic acid receptor, beta | 0.012 | Human | |
CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | 0.012 | ||
VAMP2 | vesicle-associated membrane protein 2 (synaptobrevin 2) | 0.011 | ||
TFPI2 | tissue factor pathway inhibitor 2 | 0.011 | ||
PIAS2 | protein inhibitor of activated STAT, 2 | 0.011 | ||
MSX1 | msh homeobox 1 | 0.011 | ||
FAM107A | family with sequence similarity 107, member A | 0.011 | ||
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.011 | ||
MYL6 | myosin, light chain 6, alkali, smooth muscle and non-muscle | 0.011 | ||
CCND3 | cyclin D3 | 0.011 | ||
NDRG1 | N-myc downstream regulated 1 | 0.011 | ||
TAT | tyrosine aminotransferase | 0.011 | ||
PRMT6 | protein arginine methyltransferase 6 | 0.011 | ||
NMT2 | N-myristoyltransferase 2 | 0.011 | ||
KCTD17 | potassium channel tetramerisation domain containing 17 | 0.011 | ||
TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.011 | ||
LBR | lamin B receptor | 0.011 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.011 | ||
FOXA1 | forkhead box A1 | 0.011 | ||
CTDSP2 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 | 0.011 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.011 | ||
NCOR1 | nuclear receptor corepressor 1 | 0.011 | ||
PTHLH | parathyroid hormone-like hormone | 0.011 | ||
WNT2 | wingless-type MMTV integration site family member 2 | 0.011 | ||
SMAD7 | SMAD family member 7 | 0.011 | ||
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.011 | ||
ZMYND11 | zinc finger, MYND-type containing 11 | 0.011 | ||
BCL6 | B-cell CLL/lymphoma 6 | 0.011 | ||
SPRY2 | sprouty homolog 2 (Drosophila) | 0.010 | ||
GLIS2 | GLIS family zinc finger 2 | 0.010 | ||
PRDX4 | peroxiredoxin 4 | 0.010 | ||
DLG4 | discs, large homolog 4 (Drosophila) | 0.010 | ||
MAPK14 | mitogen-activated protein kinase 14 | 0.010 | ||
TGFBR1 | transforming growth factor, beta receptor 1 | 0.010 | ||
PNRC1 | proline-rich nuclear receptor coactivator 1 | 0.010 | ||
UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.010 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.010 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.010 | ||
BARD1 | BRCA1 associated RING domain 1 | 0.010 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.010 | ||
ING3 | inhibitor of growth family, member 3 | 0.010 | ||
DAD1 | defender against cell death 1 | 0.010 | ||
MYOF | myoferlin | 0.010 | ||
PSIP1 | PC4 and SFRS1 interacting protein 1 | 0.010 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.010 | Rat | |
ANKRD12 | ankyrin repeat domain 12 | 0.010 | ||
FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.010 |